光伏视网膜植入恢复萎缩型年龄相关性黄斑变性中心视力
研究纳入5例地图状萎缩且中心视力丧失的患者,视网膜下植入PRIMA无线光伏芯片,将近红外光图像转为电流刺激内层视网膜神经元。所有患者黄斑区成功植入,均能感知可调亮度的白黄色光感;3例位置理想者假体视力20/460至20/550,1例偏位者20/800;残余自然视力未下降。
要点
- PRIMA光伏视网膜植入未降低患者残余自然视力。
- 所有5例患者原绝对暗点内恢复光感,可感知可调亮度图案。
- 3例芯片位置理想者假体视力20/460至20/550,较像素间距预期20/420低10%至30%。
核心结论
- PRIMA植入未降低残余自然视力,并在全部5例患者原暗点内恢复视觉敏感性。
研究设计与样本
- 首次人体临床试验,纳入5例地图状萎缩患者,萎缩区至少3个视盘直径,无中心凹光感,研究眼最佳矫正视力20/400至20/1000。
- 植入2毫米宽、30微米厚芯片,含378个像素,每个像素直径100微米,置于萎缩区视网膜下。
主要发现
- 全部患者芯片成功植入黄斑下,但2例植入非预期位置:1例在脉络膜内,1例偏离中心2毫米。
- 全部5例患者原暗点内可感知可调亮度的白黄色假体视觉图案。
- 3例植入位置理想者假体视力20/460至20/550,1例偏位植入者20/800。
- 任何患者植入后残余自然视力均未下降。
关键数值与推荐
- 3例芯片位置理想者假体视力20/460至20/550,较像素间距预期20/420低10%至30%。
- 1例芯片偏离中心2毫米者假体视力20/800。
临床怎么用
- PRIMA可在不损害残余自然视力前提下,为地图状萎缩患者原暗点区恢复光感与图案视觉。
- 芯片位置理想者假体视力接近像素间距预期,提示光学或电子放大及更小像素可能进一步提升视力。
局限性
- 样本量仅5例,随访至12个月,2例芯片植入非预期位置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Loss of photoreceptors in atrophic age-related macular degeneration results in severe visual impairment, although some peripheral vision is retained. To restore central vision without compromising the residual peripheral field, we developed a wireless photovoltaic retinal implant (PRIMA; Pixium Vision, Paris, France) in which pixels convert images projected from video glasses using near-infrared light into electric current to stimulate the nearby inner retinal neurons. DESIGN: We carried out a first-in-human clinical trial to test the safety and efficacy of the prosthesis in patients with geographic atrophy (ClinicalTrials.gov identifier, NCT03333954). PARTICIPANTS: Five patients with geographic atrophy zone of at least 3 optic disc diameters, no foveal light perception, and best-corrected visual acuity of 20/400 to 20/1000 in the worse-seeing study eye. METHODS: The 2-mm wide, 30-μm thick chip, containing 378 pixels (each 100 μm in diameter), was implanted subretinally in the area of atrophy (absolute scotoma). MAIN OUTCOME MEASURES: Anatomic outcomes were assessed with fundus photography and OCT for up to 12 months of follow-up. Prosthetic vision was assessed by mapping light perception, bar orientation, letter recognition, and Landolt C acuity. RESULTS: In all patients, the prosthesis was implanted successfully under the macula, although in 2 patients, it was implanted in unintended locations: within the choroid and off center by 2 mm. All 5 patients could perceive white-yellow prosthetic visual patterns with adjustable brightness in the previous scotomata. The 3 with optimal placement of the implant demonstrated prosthetic acuity of 20/460 to 20/550, and the patient with the off-center implant demonstrated 20/800 acuity. Residual natural acuity did not decrease after implantation in any patient. CONCLUSIONS: Implantation of the PRIMA did not decrease the residual natural acuity, and it restored visual sensitivity in the former scotoma in each of the 5 patients. In 3 patients with the proper placement of the chip, prosthetic visual acuity was only 10% to 30% less than the level expected from the pixel pitch (20/420). Therefore, the use of optical or electronic magnification in the glasses as well as smaller pixels in future implants may improve visual acuity even further.
引用
- Palanker D, Le Mer Y, Mohand-Said S, et al. Photovoltaic Restoration of Central Vision in Atrophic Age-Related Macular Degeneration. Ophthalmology. 2020. PMID: 32249038. doi:10.1016/j.ophtha.2020.02.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。